(Q27139708)
English
alpha-L-Fucp-(1->3)-[alpha-Neup5Ac-(2->3)-beta-D-Galp6S-(1->4)]-beta-D-GlcpNAc
chemical compound
- alpha-L-fucosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->3)-6-O-sulfo-beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosamine
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
- Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta
- N-acetyl-alpha-D-neuraminyl-(2->3)-6-O-sulfo-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosamine
- alpha-L-Fuc-(1->3)-[alpha-Neu5Ac-(2->3)-beta-D-Gal6S-(1->4)]-beta-D-GlcNAc
- Neu5Aca2-3(6S)Galb1-4(Fuca1-3)GlcNAcb
Statements
900.253±0 dalton
1 reference
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
C₃₁H₅₂N₂O₂₆S
1 reference
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)COS(=O)(=O)O)O)OC4(CC(C(C(O4)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)CO)O)NC(=O)C)O)O)O
1 reference
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)COS(=O)(=O)O)O)O[C@@]4(C[C@@H]([C@H]([C@@H](O4)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)CO)O)NC(=O)C)O)O)O
1 reference
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
Identifiers
1 reference
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
2 references
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
1 reference
(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl-(2->3)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-acetamido- (English)
7 October 2016
2 references
Neu5Acalpha2-3(6-O-Su)Galbeta1-4(Fucalpha1-3)GlcNAcbeta (English)
7 October 2016
2 references
1 reference